Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-25T10:04:28.503Z Has data issue: false hasContentIssue false
  • English
  • Français

An Open Clinical Trial of Carbamazepine in Treatment-Resistant Bipolar and Schizo-Affective Psychotics

Published online by Cambridge University Press:  29 January 2018

Martin Elphick
Martin Elphick*
Affiliation:
Oxford Rotational Training Scheme, c/o Warneford Hospital, Headington, Oxford, OX3 7JX
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 147 , Issue 2 , August 1985 , pp. 198 - 200
Copyright
Copyright © 1985 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dalby, M. A. (1971) Anti-epileptic and psychotropic effect of carbamazepine in the treatment of psychomotor epilepsy. Epilepsia, 12, 325–334.CrossRefGoogle ScholarPubMed
Dunner, D. L. & Fieve, R. R. (1974) Clinical factors in lithium carbonate prophylaxis failure. Archives of General Psychiatry, 30, 229–253.CrossRefGoogle ScholarPubMed
Hakola, H. P. A. & Laulumaa, V. A. (1982) Carbamazepine in violent schizophrenics. Lancet, 1, 1358.Google Scholar
Kishimoto, A., Ogyra, C., Hazama, H. & Inoye, K. (1983) Long term prophylactic effects of carbamazepine in affective disorders. British Journal of Psychiatry, 143, 327–331.Google Scholar
Nolen, W. A. (1983) Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder. Acta Psychiatrica Scandinavica, 67, 218–225.CrossRefGoogle ScholarPubMed
Okuma, T., Inanaea, K. Otsuki, S. et al (1979) Comparison of the anti-manic efficacy of carbamazepine and chlorpromazine: a double blind controlled study. Psychopharmacology, 66, 211–217.Google Scholar
Okuma, T., Kazutoyo, I., Otsuki, S., et al (1981) A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic depressive illness. Psychopharmacology, 73, 95–96.Google Scholar
Overall, J. E. & Gorham, D. R. (1962) Brief psychiatric rating scale. Psychology Reports, 10, 799–812.Google Scholar
Post, R. M. & Uhde, T. W. (1983) Alternatives to lithium: a focus on carbamazepine. Affective Disorders Reassessed: 1983 (ed. Ayd, Frank J.)Google Scholar
Prien, R. F., Caffey, E. M. & Klett, C. J. (1973) Prophylactic efficacy of lithium carbonate in manic depressive illness. Archives of General Psychiatry, 28, 337–341.Google Scholar
Spitzer, R. L., Endicott, J. & Robins, E., (1978) Research Diagnostic Criteria for a selected group of Functional Disorders. Third edition. New York: Biometrics Research.Google Scholar
Taylor, J. C., Brauer, S. & Espir, M. L. E. (1981) Carbamazepine treatment for trigeminal neuralgia. Postgraduate Medical Journal, 57, 16–18.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.